Our first month of delivering the prostate cancer diagnostic pathway within the limitations of COVID‐19 using local anaesthesia transperineal biopsy

Authors:

Abstract
The COVID‐19 pandemic is impacting all urological cancer services. On March 19th the British Association of Urological Surgeons (BAUS) provided pragmatic guidance for prostate cancer diagnostic services (Table 1 ).(1)